FDA Approved: ZYKADIA — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for ZYKADIA (ceritinib) submitted by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zykadia (ceritinib)

Snippet

SUPPL AP for ZYKADIA (CERITINIB)